White Paper

COVID-19 Vaccination and Coverage under Workers’ Compensation

The continuing rollout of the COVID-19 vaccine, while welcome, brings questions regarding coverage that is new to the workers’ compensation pharmaceuticals field.
By:

White Paper Summary

This is an emerging and evolving topic that the entire myMatrixx team is keeping a close eye on. To provide essential information about the vaccine, drug therapy in general, and the most up-to-date formulary considerations, we recently released a whitepaper sharing the myMatrixx position on Position Paper regarding COVID-19 Vaccination and Coverage under Workers’ Compensation.

The paper provides an overview of the cost of the vaccine, associated administration fees, reimbursement guidelines, formulary considerations and efficacy rates, particularly as they may apply to the workforce. There are also sections covering herd immunity, the emergence of new COVID-19 strains and vaccine availability as these continue to be significant areas of concern around the pandemic.

Register to download the full content

 

To learn more about myMatrixx, please visit their website.

myMatrixx® is a pharmacy benefit management company dedicated to workers’ compensation. The unique combination of myMatrixx and Express Scripts makes us the only workers’ compensation pharmacy benefit manager that can deliver high touch customer service, clinical expertise and actionable data analytics while leveraging Express Scripts’ pharmacy network, comprehensive clinical services, mail order program and specialty solutions to meet the individual needs of our clients and their injured workers. For more information, visit myMatrixx.com.

More from Risk & Insurance

More from Risk & Insurance

Risk Matrix: Presented by Liberty Mutual Insurance

9 Ways Societal Views Affect Businesses and Bring About New Risk

The way society interacts with and views businesses has shifted in recent years. From a higher demand for corporate social responsibility to a bigger virtual presence, here’s how society is changing the risk landscape.
By: | April 1, 2021




The R&I Editorial Team can be reached at [email protected]